# Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

> **NCT07264998** · — · RECRUITING · sponsor: **Hubei Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Neoplasms
- Hormone Receptor-Positive Breast Cancer
- Abemaciclib
- Abemaciclib-related Diarrhea
- Drug-induced Diarrhea
- Gastrointestinal Microbiome (Focus)
- Microbiome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07264998
- **Lead sponsor:** Hubei Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-21
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07264998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07264998, "Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07264998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*